Holen Sie sich die Stockscreener-App
3.01
3.22%
-0.10
Handel nachbörslich:
3.07
0.06
+1.99%
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
NRx Pharmaceuticals: Pioneering Mental Health Innovation Through Clinical and Operational Synergy - AInvest
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - The Globe and Mail
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - Yahoo Finance
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner's National Priority Voucher for IV Ketamine NRX-100 - Yahoo Finance
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics - Eastern Progress
HOPE Therapeutics To Buy 49% Stake In Florida Neuropsychiatry Clinic Cohen And Associates - Nasdaq
NRXP SEC FilingsNrx Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NRXP: Analyst Maintains 'Buy' Rating with Target Price Firm at $31 | NRXP Stock News - GuruFocus
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100) - PR Newswire
New to The Street Show #673 Airs Nationwide on Bloomberg TVSaturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQThe Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella - Detroit Free Press
NRx Pharmaceuticals (NRXP) Plans $150M Securities Offering - GuruFocus
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Joplin Globe
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners - financial-news.co.uk
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners - StreetInsider
NRx Pharmaceuticals Taps Top Biotech IR Firm ahead of Critical FDA Filings and Clinic Acquisitions - Stock Titan
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP) - Livingston Daily
NRX Pharmaceuticals: A Promising Investment with Innovative Growth and Strong Financial Outlook - TipRanks
Safety scares and trial misses drag down neuro biotechs into Q2 - BioWorld MedTech
NRx Pharmaceuticals CEO Set to Reveal Latest Advances at Major Neuroscience Investment Conference - Stock Titan
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Quantisnow
Squarepoint Ops LLC Makes New Investment in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) - Defense World
NRX Pharmaceuticals Submits FDA Application for NRX-100 - TipRanks
New to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor Platforms - USA Today
NRx Pharmaceuticals’ (NRXP) Buy Rating Reaffirmed at D. Boral Capital - Defense World
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network - Barchart.com
NRX Pharmaceuticals: Strategic Positioning and Market Potential Drive Buy Rating - TipRanks
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025 - mx.advfn.com
NRx Pharmaceuticals files for preservative-free ketamine By Investing.com - Investing.com South Africa
$750 Million Market Projected to Reach $3.35 Billion Globally - openPR.com
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine - Yahoo Finance
Why Ciena Stock Is Plummeting Today - The Globe and Mail
$750 Million Market Projected to Reach $3.35 Billion Globally in 2034 for Abbreviated New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
$750 Million Market Projected to Reach $3.35 Billion Globally in 2034 for Abbreviated New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) | FinancialContent - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine - TipRanks
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine - GuruFocus
NRx Pharmaceuticals files for preservative-free ketamine - Investing.com Australia
NRXP Advances FDA Application for IV Ketamine With Preservative-Free Formulation | NRXP Stock News - GuruFocus
NRX Pharmaceuticals Seeks FDA's Priority Review for Preservative-Free IV Ketamine - MarketScreener
Why Overall Consumer Confidence Is Critical to the Markets You Follow - The Globe and Mail
Public market insider buying at Tourmaline Oil (TOU) - The Globe and Mail
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network - MSN
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval - Yahoo Finance
3.40%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):